Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxycodone-naloxone for bowel dysfunction after C-section
NCT02571881Phase 4Unknown
- Sponsor
- Kuopio University Hospital
- Start
- Oct 2012
- Primary completion
- Dec 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of oxycodone + naloxone in opioid-induced bowel dysfunction (OIBD) (2 arms), sponsored by Kuopio University Hospital. Primary endpoint: Bowel Function Index at 3 weeks. Status: unknown.
02
Drugs
oxycodone + naloxone
03
Conditions
opioid-induced bowel dysfunction (OIBD)
Beyond the preview
Go deeper on NCT02571881.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02571881.